amcp vs amcp nexus
Why Semaglutide Finally Makes Sense for Obesity?
In 2024, oral semaglutide made sense for obesity because it achieved a 10-15% weight loss, matching injectable outcomes while improving adherence and lowering overall costs. The pill’s convenience has driven rapid uptake among prescribers and insurers, reshaping how we address chronic weight management. Medical Disclaimer: This article is for